Metraipolis › archive › dc_0d04243dd059

CTSL loss leads to anti-PD-1 immunotherapy resistance in lung cancer by suppressing the anti-tumor function of peripheral CD8+ T cells — Europe PMC PMID:42358957

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42358957
DOI
10.3389/fimmu.2026.1863563
License (as archived)
solo-consultazione
Archived
2026-10-31T14:30:26.200Z
SHA-256 of the archived text
15ee7739322ab457de029bfa0af4ce65670371db501b47a896e738c7bfe91413
Stable URL of this page
https://metraipolis.com/documento/dc_0d04243dd059

How to cite

CTSL loss leads to anti-PD-1 immunotherapy resistance in lung cancer by suppressing the anti-tumor function of peripheral CD8+ T cells — Europe PMC PMID:42358957 — Europe PMC (en), https://europepmc.org/article/MED/42358957 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0d04243dd059 (Metraipolis archive dc_0d04243dd059, sha256 15ee7739322ab457de029bfa0af4ce65670371db501b47a896e738c7bfe91413)
BibTeX
@misc{dc0d04243dd059,
  title = {CTSL loss leads to anti-PD-1 immunotherapy resistance in lung cancer by suppressing the anti-tumor function of peripheral CD8+ T cells — Europe PMC PMID:42358957},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42358957},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0d04243dd059; sha256 15ee7739322ab457de029bfa0af4ce65670371db501b47a896e738c7bfe91413},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42358957. Agents can read the archived copy with the MCP tool read_document.